age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
76.91998
female
0
30
Coma
Coma
1
null
null
9
57,527
43,478.3125
40,821.875
24.75
white
30.398438
43
0.269958
0.200989
8
0
0
no
0.7
0.6
no dnr
30
106
16.398438
75
60
36
127.98438
null
1.599854
0.799927
131
7.439453
null
null
null
null
null
null
2.306152
1,657
0
71.84094
male
0
6
COPD
COPD/CHF/Cirrhosis
1
6
$11-$25k
0
9,770
7,548.2852
6,869.55859
17
white
21.097656
33
0.817993
0.703979
1
0
0
no
0.8
0.8
no dnr
6
109
22.199219
106
32
36.09375
196.28125
3.399902
0.599976
1.099854
137
7.479492
null
null
null
0
1
no(M2 and SIP pres)
1
1,655
0
73.14197
male
0
4
Lung Cancer
Cancer
3
null
under $11k
0
8,258
5,899.8984
7,148.26953
2
white
14.099609
15
0.691895
0.401978
6
0
0
metastatic
0.5
0.4
dnr before sadm
-5
69
null
98
23
38.39844
null
null
null
null
140
null
null
null
null
null
null
SIP>=30
2.769531
104
1
50.431
female
0
9
CHF
COPD/CHF/Cirrhosis
3
15
$11-$25k
0
9,614
7,212.3164
6,459.1875
16
white
28.296875
27
0.80896
0.691895
1
0
0
no
0.8
0.7
no dnr
9
74
17.296875
113
24
36.29688
144.875
3.799805
0.899902
1.899902
142
7.419922
null
null
null
0
0
no(M2 and SIP pres)
0
1,654
0
45.01797
male
0
6
Cirrhosis
COPD/CHF/Cirrhosis
2
10
under $11k
0
4,175
3,112.6426
2,915.05859
4
white
22.097656
24
0.836914
0.733887
1
0
0
no
1
1
no dnr
6
111
8.5
106
22
36.09375
423.75
2
2.099609
1.199951
130
7.509766
null
null
null
0
0
no(M2 and SIP pres)
0
1,654
0
81.86694
female
0
5
COPD
COPD/CHF/Cirrhosis
4
10
under $11k
0
3,919
2,813.0059
2,688.92969
15
white
19
23
0.786987
0.657959
1
0
0
no
0.8
0.7
no dnr
5
83
13.199219
94
16
35.5
257.125
3.599609
0.5
1.299805
136
7.369141
null
null
null
1
null
SIP>=30
1.1669
623
1
68.25494
female
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
15,990
12,494.8281
11,592.9062
34.5
white
30.898438
63
0.670898
0.574951
1
0
0
no
0.9
0.8
no dnr
9
71
26.097656
176
8
36.5
198
2.799805
0.599976
7
131
7.379883
null
null
null
null
0
<2 mo. follow-up
0
9
1
66.98199
female
0
10
COPD
COPD/CHF/Cirrhosis
1
13
$11-$25k
0
14,576
10,641.5156
10,258.8594
6.5
white
15.298828
27
0.87793
0.796997
5
0
0
no
0.9
0.7
no dnr
10
105
null
70
30
37.79688
207.125
null
null
1
142
7.369141
null
null
null
1
0
SIP>=30
0
1,651
0
37.35498
male
0
275
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$11-$25k
0
515,884
393,331.25
388,801.25
40.5
white
30.398438
50
0.747925
0.667969
2
1
0
yes
0.7
0.6
dnr after sadm
83
62
21.5
129
30
37.5
124.48438
2
0.299988
1.899902
139
7.349609
null
null
null
null
6
adl>=4 (>=5 if sur)
6
386
1
89.61499
female
0
3
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
3,340
2,736.7285
2,654.57812
17
white
14.199219
15
0.815918
0.700928
1
0
0
yes
0.25
0.25
no dnr
3
90
6
70
20
36.5
395
3.599609
1
1.299805
141
7.349609
null
null
null
4
null
SIP>=30
3.183199
393
1
91.18994
female
0
10
CHF
COPD/CHF/Cirrhosis
2
8
under $11k
0
6,592
5,046.0312
4,376.25781
7
white
16.398438
27
0.819946
0.706909
1
0
0
no
0.7
0.343
no dnr
10
70
6.799805
62
24
35
476.625
4
0.799927
1.299805
136
7.479492
null
null
null
2
3
no(M2 and SIP pres)
3
634
1
66.86896
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
$11-$25k
0
24,721
20,425.1406
19,053.4688
20.333328
white
42.59375
62
0.365967
0.247986
1
1
0
no
0.5
0.35
no dnr
15
59
16.597656
122
40
35.39844
326.625
2.799805
1.299805
2
116
7.429688
null
null
null
0
0
no(M2 and SIP pres)
0
448
1
64.17499
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
3
6
under $11k
0
6,206
4,584.9414
4,141.03906
14
white
17.296875
5
0.806885
0.687988
1
0
0
no
0.85
0.75
no dnr
8
81
6.399414
98
20
37
428.5625
3
0.599976
0.799927
132
7.459961
null
null
null
1
0
SIP>=30
0
1,647
0
79.01697
female
0
4
Lung Cancer
Cancer
2
7
under $11k
0
2,480
1,898.6211
1,680.84961
10
black
13.398438
26
0.744995
0.481995
1
0
0
metastatic
0.15
0.2
dnr after sadm
2
105
6.399414
60
22
36.39844
null
4
0.399963
1.599854
132
7.439453
null
null
null
null
null
<2 mo. follow-up
2.749023
30
1
83.15399
male
0
8
MOSF w/Malig
ARF/MOSF
1
7
under $11k
0
6,988
4,875.9414
5,158.13672
14.5
white
27.199219
32
0.5979
0.490967
1
0
0
yes
0.5
0.3
dnr after sadm
4
66
1.099854
58
22
35.5
null
2.699707
0.899902
0.899902
134
null
null
null
null
null
0
adl>=4 (>=5 if sur)
0
127
1
93.22699
female
0
22
Coma
Coma
3
8
under $11k
44
16,027
12,126.0312
11,384.1875
19
white
16.699219
28
0.330994
0.258972
1
0
1
yes
0.5
0.4
dnr after sadm
1
79
9.199219
76
24
36.5
556.625
2.899902
0.5
0.599976
133
7.469727
null
null
null
null
7
adl>=4 (>=5 if sur)
7
101
1
64.909
female
1
5
MOSF w/Malig
ARF/MOSF
2
13
under $11k
9
15,017
10,283.2812
10,912.4297
19
white
45.898438
75
0.016998
0.003
10
0
0
metastatic
null
null
dnr after sadm
2
41
0.099991
180
24
36.29688
null
2.399902
1.399902
1.799805
133
null
null
null
null
null
2
<2 mo. follow-up
2
5
1
35.06097
female
0
18
MOSF w/Malig
ARF/MOSF
1
14
$25-$50k
0
19,369
13,598.0312
15,257.4688
20.666656
white
25.398438
30
0.67688
0.582886
3
0
0
yes
0.7
0.6
no dnr
18
72
0.149994
96
22
38.29688
null
null
null
0.599976
136
null
null
null
null
1
0
no(M2 and SIP pres)
0
118
1
60.452
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
null
100
32,150
23,731.8125
22,376.8906
29
white
34.398438
76
0.033997
0.008999
17
0
0
yes
null
null
dnr before sadm
0
53
27.796875
100
12
36.89844
125
1.299805
5.599609
1.5
137
7.349609
null
null
null
null
null
<2 mo. follow-up
3.854981
3
1
69.93799
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
28,396
22,406.625
20,418.4844
13.5
white
19.398438
59
0.849976
0.797974
1
0
0
no
0.95
0.95
no dnr
29
68
9.699219
73
32
37.59375
300.375
2.199707
2.099609
2
138
7.449219
null
null
null
0
null
no(M2 and SIP pres)
0.4948
1,639
0
52.73398
female
0
20
MOSF w/Malig
ARF/MOSF
1
16
>$50k
41
35,241
50,658.9688
50,985.8125
41.333313
white
26.898438
31
0.261963
0.155975
14
0
0
metastatic
0.5
0.3
no dnr
20
61
37.796875
47
14
37.59375
122.21875
2.899902
0.799927
0.599976
139
7.229492
null
null
null
null
0
null
0
74
1
58.90198
male
0
4
CHF
COPD/CHF/Cirrhosis
3
8
$11-$25k
0
2,795
2,089.5195
1,794.08984
3
white
16.199219
18
0.908936
0.845947
1
0
0
no
1
0.9
no dnr
4
127
4.899414
60
22
35.89844
null
8.599609
0.699951
0.799927
142
null
null
null
null
null
null
no(M2 and SIP pres)
2.312012
1,598
1
45.57999
female
0
8
Lung Cancer
Cancer
2
null
null
0
7,759
6,144.3945
6,046.57812
7.5
white
16.296875
11
0.762939
0.511963
1
0
0
metastatic
0.5
0.4
dnr after sadm
1
63
16.597656
72
24
35.79688
null
3.599609
0.299988
0.899902
136
null
null
null
null
null
null
<2 mo. follow-up
3.447266
27
1
74.63098
male
1
10
ARF/MOSF w/Sepsis
ARF/MOSF
3
9
$11-$25k
0
17,657
13,710.0078
13,378.7734
15
white
34.59375
46
0.464966
0.345947
6
1
0
no
0.1
0.001
dnr after sadm
2
67
18.097656
138
16
36.39844
null
null
null
2.099609
121
null
null
null
null
7
7
<2 mo. follow-up
7
10
1
76.58899
female
0
8
MOSF w/Malig
ARF/MOSF
1
6
under $11k
0
8,191
6,202.5859
6,086.77734
17
white
25.296875
19
0.61499
0.509888
3
0
0
yes
0.7
0.7
no dnr
8
126
1.799805
64
20
36.39844
null
null
null
0.599976
134
null
null
null
null
4
1
no(M2 and SIP pres)
1
1,635
0
60.98599
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
$11-$25k
0
89,069
63,768.75
62,352.4688
23.75
white
27.398438
47
0.701904
0.611938
12
0
0
no
0.5
0.5
no dnr
29
108
9.898438
107
30
38.39844
337.5
1.899902
23.597656
0.899902
138
7.439453
null
null
null
null
0
SIP>=30
0
1,636
0
72.31799
male
0
5
Cirrhosis
COPD/CHF/Cirrhosis
2
16
null
0
3,561
2,611.6152
2,405.89844
17
white
16.5
34
0.773926
0.639893
1
0
0
no
null
null
no dnr
5
63
5.799805
60
16
36.5
null
1.899902
1.299805
1.399902
137
null
null
null
null
null
null
adl>=4 (>=5 if sur)
2.315918
158
1
44.02499
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
2
null
null
9
26,237
20,897.1562
19,660.9375
22.666656
black
38.695313
50
0.584961
0.474976
1
1
0
no
0.3
0.3
no dnr
21
110
16.097656
131
29
35.39844
136.71875
3.099609
1.099854
3.699707
134
7.349609
null
null
null
null
null
null
3.769043
278
1
57.49799
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
23,609
17,487.375
17,101.0469
20.333328
white
26.5
29
0.718994
0.632935
3
0
0
yes
0.25
0.25
no dnr
15
65
2.199707
108
14
36.59375
316
2.199707
0.599976
0.699951
132
7.519531
null
null
null
null
1
no(M2 and SIP pres)
1
1,634
0
62.47198
male
0
8
Lung Cancer
Cancer
1
15
$25-$50k
0
14,028
11,103.7266
11,468.9297
19
white
15.398438
9
0.743896
0.480957
1
0
0
metastatic
1
1
no dnr
8
108
5.799805
76
14
36.39844
336
null
null
0.799927
135
7.469727
null
null
null
0
0
no(M2 and SIP pres)
0
1,636
0
47.89297
male
0
13
CHF
COPD/CHF/Cirrhosis
3
16
under $11k
0
12,490
9,780.9297
8,985.85938
16.5
black
22
36
0.886963
0.810913
1
1
0
no
0.98
0.98
no dnr
13
123
3.299805
94
24
36.09375
327.125
3.299805
0.399963
7.299805
140
7.389648
null
null
null
0
null
no(M2 and SIP pres)
0.4948
1,567
1
47.47699
male
0
87
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
0
144,883
105,295.938
103,955.562
45.5
black
26
44
0.803955
0.738892
5
1
0
no
0.6
0.6
no dnr
87
53
12.798828
112
14
36.79688
290
1.299805
0.899902
0.699951
148
7.489258
null
null
null
null
null
SIP>=30
2.452637
1,635
0
66.07495
female
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
37
24,990
19,123.7969
17,230.7812
24
white
23.398438
51
0.701904
0.612915
1
0
0
no
0.25
0.2
no dnr
23
57
14
105
36
38.09375
180
1.599854
0.299988
1.199951
141
7.40918
null
null
null
null
6
adl>=4 (>=5 if sur)
6
274
1
71.95599
female
0
7
MOSF w/Malig
ARF/MOSF
2
null
null
0
7,521
5,667.1562
5,610.46875
17
black
27.898438
32
0.450989
0.330994
5
0
0
metastatic
0
0
no dnr
7
72
0.799927
79
22
35.39844
null
null
null
0.5
143
null
null
null
null
null
6
<2 mo. follow-up
6
22
1
27.85799
female
0
11
Cirrhosis
COPD/CHF/Cirrhosis
2
12
null
0
8,972
6,571.5312
5,921.52734
9.5
white
29.199219
30
0.828979
0.720947
1
0
0
no
0.98
0.98
no dnr
11
67
15
102
20
37.19531
350
2.099609
4.299805
0.299988
127
7.469727
null
null
null
4
2
no(M2 and SIP pres)
2
1,634
0
73.81
male
0
5
COPD
COPD/CHF/Cirrhosis
2
6
under $11k
0
6,665
5,066.7617
4,746.41797
22
white
25
39
0.684937
0.517944
1
0
0
yes
0.9
0.6
dnr after sadm
1
103
7.599609
189
30
36.19531
222.21875
3.099609
0.299988
0.799927
137
7.479492
null
null
null
1
null
no(M2 and SIP pres)
1.1669
218
1
40.77798
male
0
4
CHF
COPD/CHF/Cirrhosis
3
10
under $11k
0
2,707
2,048.6641
1,994.8291
8
black
22.898438
39
0.895996
0.825928
1
0
0
no
null
null
no dnr
4
118
8
110
40
35.09375
269.5
4
2.099609
1.399902
140
7.40918
null
null
null
null
null
SIP>=30
2.509766
1,633
0
62.80399
male
0
8
Cirrhosis
COPD/CHF/Cirrhosis
4
9
null
0
6,059
4,487.9258
4,247.00781
8
white
31.296875
51
0.527954
0.327942
1
0
0
no
0.75
0.5
dnr after sadm
3
104
5.599609
136
25
36.29688
447.5625
2
12.898438
0.5
136
7.459961
null
null
null
1
2
no(M2 and SIP pres)
2
1,503
1
83.76996
female
0
19
Coma
Coma
1
5
under $11k
44
16,348
13,164.0156
11,513.8672
11.666664
black
16.796875
35
0.483948
0.411987
2
0
1
no
0.5
0.2
dnr after sadm
1
125
12.898438
83
34
36.39844
226.65625
2.699707
0.799927
1
138
7.529297
null
null
null
null
2
adl>=4 (>=5 if sur)
2
1,630
0
39.56998
female
1
6
Lung Cancer
Cancer
2
null
under $11k
0
4,717
3,545.166
3,507.32812
10
white
39.695313
28
0.181
0.014999
1
0
0
metastatic
0
0
dnr after sadm
1
66
13.298828
70
24
35.09375
null
1.399902
0.599976
0.399963
147
null
null
null
null
null
null
<2 mo. follow-up
3.17627
6
1
81.90594
female
0
33
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
0
57,319
41,473.8438
43,395.5312
29
white
13.298828
29
0.852905
0.756958
1
0
0
yes
0.9
0.9
no dnr
33
103
10.199219
64
16
36.09375
281.875
4.5
1.299805
1.199951
134
7.489258
null
null
null
null
5
SIP>=30
5
1,489
1
55.01199
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
9
null
0
12,360
9,786.9609
8,781.44531
14
white
27.699219
32
0.737915
0.656982
1
0
0
yes
1
0.8
no dnr
12
65
9.099609
104
30
36
115
3.599609
0.299988
0.599976
139
7.40918
null
null
null
1
1
no(M2 and SIP pres)
1
1,629
0
36.97699
male
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
6,816
4,874.2539
4,765.50781
12.5
white
14.699219
10
0.942993
0.921997
1
1
0
no
1
1
no dnr
8
103
null
75
14
37
433.3125
2.599609
0.699951
0.599976
139
7.439453
null
null
null
null
0
no(M2 and SIP pres)
0
1,627
0
82.32196
female
0
41
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
43,100
33,070.25
31,587.75
21.75
white
18.699219
20
0.80188
0.736938
1
0
0
no
0.5
0.1
no dnr
41
145
15.099609
60
14
36.69531
229.15625
2.699707
0.399963
0.599976
137
7.399414
null
null
null
null
null
null
2.809082
568
1
40.59698
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
8,025
6,036.043
5,883.17969
2.5
white
20.5
17
0.903931
0.869995
1
1
0
no
0.9
0.8
no dnr
7
138
18
93
20
35.69531
485.6875
3.399902
0.799927
0.699951
137
7.709961
null
null
null
1
1
no(M2 and SIP pres)
1
1,627
0
43.95599
male
1
28
Cirrhosis
COPD/CHF/Cirrhosis
3
16
under $11k
0
38,219
28,785.4219
27,691.8594
24.5
white
44.195313
83
0.35498
0.163971
1
0
0
no
0.2
0.2
dnr after sadm
25
70
29.296875
100
20
36.5
152.375
2.799805
21.597656
3
126
7.479492
null
null
null
6
6
<2 mo. follow-up
6
28
1
66.80396
male
0
115
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
null
0
244,096
167,700.625
167,011.25
54.5
white
28.597656
54
0.555908
0.442993
27
0
0
yes
null
null
no dnr
115
65
21.296875
128
29
38.79688
215
1.399902
4
1.5
131
7.379883
null
null
null
null
null
Coma or Intub
2.700684
116
1
89.38495
female
1
20
MOSF w/Malig
ARF/MOSF
2
9
under $11k
44
15,973
11,722.5391
12,631.5547
14.333328
black
24.597656
44
0.356995
0.238983
1
0
1
metastatic
0.5
0.25
dnr before sadm
-1
55
9.398438
112
24
38.19531
580
3
2.799805
1.799805
143
7.40918
null
null
null
null
7
<2 mo. follow-up
7
20
1
57.60699
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$25-$50k
0
31,984
24,273.5625
24,288.0156
33.333313
white
26.699219
60
0.743896
0.66394
7
0
0
no
0.6
0.6
no dnr
15
115
16.296875
124
32
38.69531
311.1875
2.099609
2.099609
2.299805
138
7.339844
null
null
null
null
1
no(M2 and SIP pres)
1
163
1
31.20099
female
1
13
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
$11-$25k
0
38,936
31,662.0625
30,075.1094
48.5
white
31.5
45
0.815918
0.753906
1
1
0
no
0.5
0.5
dnr after sadm
9
70
9.5
122
34
39.29688
59.19531
2.399902
0.699951
0.799927
135
7.399414
null
null
null
null
0
<2 mo. follow-up
0
13
1
37.91397
male
0
14
MOSF w/Malig
ARF/MOSF
1
15
under $11k
0
14,411
10,678.875
10,848.125
13.333328
white
25.398438
34
0.591919
0.482971
4
0
0
metastatic
0.7
0.4
no dnr
14
103
6.799805
128
24
38.69531
null
null
null
3.5
137
null
null
null
null
1
2
<2 mo. follow-up
2
58
1
73.02899
female
0
12
Coma
Coma
2
12
>$50k
9
15,104
11,376.9453
11,052.9062
26
white
22.398438
38
0.54895
0.480957
1
1
0
yes
0.75
0.75
no dnr
12
104
10.099609
160
28
37.79688
297.5625
2.799805
0.399963
0.5
143
7.429688
null
null
null
null
7
adl>=4 (>=5 if sur)
7
1,617
0
61.34698
male
1
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
null
9
55,068
40,111.0938
40,412.1562
53.333313
white
38.5
68
0.383972
0.265991
8
0
0
no
0
0
dnr after sadm
4
67
37.398438
118
38
40.19531
131.40625
2.5
4.199219
2.599609
143
7.459961
null
null
null
null
0
<2 mo. follow-up
0
15
1
78.98199
female
0
8
CHF
COPD/CHF/Cirrhosis
4
14
null
9
9,911
8,030.6055
7,240.91797
6
black
20.597656
27
0.784912
0.655884
1
1
0
no
0.9
0.5
dnr after sadm
2
110
16.597656
97
24
36.39844
460
null
0.799927
1.599854
134
7.509766
null
null
null
0
null
SIP>=30
0.4948
148
1
78.40698
female
1
21
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
$11-$25k
0
42,104
32,445.1406
31,676.375
23.666656
black
14.798828
15
0.8479
0.795898
6
1
0
no
0.8
0.5
dnr after sadm
19
68
9.798828
61
10
38.79688
240
2.599609
0.599976
1
145
7.449219
null
null
null
null
1
<2 mo. follow-up
1
21
1
88.59998
female
0
3
COPD
COPD/CHF/Cirrhosis
2
5
null
0
2,138
1,544.082
1,489.72949
9
white
17.597656
29
0.761963
0.622925
1
0
0
no
0.7
0.5
no dnr
3
100
13.699219
126
20
36.5
231.1875
4.199219
0.399963
0.699951
143
7.379883
null
null
null
2
null
SIP>=30
1.839
1,614
0
74.396
female
0
12
Cirrhosis
COPD/CHF/Cirrhosis
6
11
under $11k
0
22,765
17,024.2969
16,646.6562
25
white
21.199219
46
0.633911
0.451965
3
1
0
no
null
null
no dnr
12
59
6
110
20
37.69531
470
2.299805
3.799805
1
132
7.429688
null
null
null
1
1
SIP>=30
1
260
1
61.711
female
0
3
Lung Cancer
Cancer
3
9
under $11k
0
2,241
1,491.46
1,660.98926
18
white
16.097656
15
0.73291
0.463989
1
1
0
metastatic
null
null
no dnr
3
121
8
98
20
37.5
null
null
null
0.699951
140
null
null
null
null
null
null
SIP>=30
2.791504
113
1
46.97598
female
0
3
Lung Cancer
Cancer
1
14
under $11k
0
4,465
2,777.5527
4,445.56641
10
white
13.099609
5
0.80896
0.590942
1
0
0
metastatic
null
null
no dnr
3
97
6.5
66
22
37.09375
null
3.699707
0.5
0.599976
139
null
null
null
null
null
null
SIP>=30
2.23877
128
1
49.48099
female
0
5
Cirrhosis
COPD/CHF/Cirrhosis
1
9
null
0
3,999
2,799.4941
2,943.11914
9
white
26.199219
35
0.753906
0.610962
1
0
0
no
null
null
no dnr
5
57
4.699219
100
22
37.39844
null
2.699707
5.399414
0.599976
130
null
null
null
null
null
null
adl>=4 (>=5 if sur)
2.373047
1,613
0
82.20898
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
2
16
$11-$25k
0
16,802
13,449.875
12,862.4453
13.5
white
21.398438
35
0.734985
0.652954
1
0
0
yes
1
0.8
no dnr
12
117
6.899414
69
26
36.09375
339.5625
3
0.299988
2.5
140
7.40918
null
null
null
0
0
no(M2 and SIP pres)
0
1,613
0
77.46997
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
$11-$25k
37
8,682
6,913.1758
6,657.02734
14
white
23.5
30
0.639893
0.53894
1
0
0
no
0.7
0.5
no dnr
8
135
7.899414
63
16
36.69531
71.42188
null
null
0.899902
141
7.359375
null
null
null
null
7
adl>=4 (>=5 if sur)
7
1,613
0
42.09399
female
0
4
Cirrhosis
COPD/CHF/Cirrhosis
4
12
$25-$50k
0
2,058
1,570.3447
1,500.56934
6
white
28.597656
30
0.759888
0.619995
1
0
0
no
null
null
no dnr
4
69
13.199219
98
24
36.19531
null
2.099609
3.799805
0.599976
125
null
null
null
null
null
null
null
3.067383
1,612
0
37.51099
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
under $11k
0
31,305
20,700.5625
21,454.25
62.5
black
30.199219
44
0.79895
0.73291
2
1
0
no
0.5
0.125
dnr after sadm
7
66
3
140
14
38.79688
150
1
0.899902
1.099854
154
7.419922
null
null
null
null
6
<2 mo. follow-up
6
8
1
91.60297
male
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
26
92,223
67,052.5
65,246.5312
45.666657
black
38.59375
56
0.090988
0.035995
20
1
0
no
null
null
no dnr
14
38
18
82
10
35.39844
189.3125
2.299805
0.699951
1.699951
132
7.459961
null
null
null
null
5
<2 mo. follow-up
5
14
1
64.06299
female
0
21
Colon Cancer
Cancer
3
2
under $11k
9
17,616
13,505.1328
13,261.8047
13.666664
white
36.398438
28
0.33197
0.064987
1
1
0
metastatic
null
null
dnr after sadm
4
79
20.398438
102
24
36.5
null
2.299805
1.199951
0.5
133
null
null
null
null
null
6
<2 mo. follow-up
6
23
1
62.34097
female
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
36,127
28,923.5781
27,897.4062
28.333328
white
46.898438
71
0.211975
0.116989
4
0
0
no
0.65
0.5
no dnr
14
38
4.799805
120
24
37.59375
null
2.599609
17.898438
10.398438
134
null
null
null
null
null
null
<2 mo. follow-up
3.279785
14
1
80.66498
female
1
5
Coma
Coma
2
12
null
44
28,454
23,329.7031
22,635.75
47
white
30
53
0.051994
0.026997
8
0
0
yes
0.1
0.001
dnr after sadm
1
68
12.398438
70
26
38.79688
180
2.099609
0.5
4.199219
126
7.469727
null
null
null
null
3
<2 mo. follow-up
3
5
1
65.48395
female
0
55
Coma
Coma
2
16
under $11k
0
117,667
97,933.875
88,912.125
46.75
black
25
43
0.589966
0.524902
1
0
0
yes
0.3
0.2
no dnr
55
61
22.898438
70
12
34.79688
160
2.199707
0.899902
1.099854
134
7.279297
null
null
null
null
7
adl>=4 (>=5 if sur)
7
104
1
57.69199
female
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
under $11k
0
11,586
7,908.2656
8,443.84375
22
white
28.699219
61
0.707886
0.619995
1
0
0
yes
0.8
0.8
no dnr
11
72
0.599976
97
36
38.09375
252.375
2.599609
3.199707
1.099854
132
7.469727
null
null
null
null
0
no(M2 and SIP pres)
0
927
1
67.06598
female
0
12
COPD
COPD/CHF/Cirrhosis
2
2
under $11k
0
10,151
7,150.9766
6,457.70703
7
white
20.097656
29
0.85498
0.760986
1
0
0
no
0.95
0.95
no dnr
12
130
15.099609
114
28
35.69531
233.3125
4.399414
0.399963
0.699951
133
7.449219
null
null
null
5
6
no(M2 and SIP pres)
6
1,605
0
37.40698
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
under $11k
0
15,144
11,418.4609
11,035.5469
24
white
24.199219
31
0.879883
0.837891
1
1
0
no
0.9
0.7
no dnr
10
82
11.099609
100
24
36.19531
384.25
2.099609
3
0.399963
138
7.399414
null
null
null
2
1
no(M2 and SIP pres)
1
1,602
0
77.84497
male
0
33
MOSF w/Malig
ARF/MOSF
1
null
under $11k
0
29,913
21,028.9688
21,573.8438
17.75
white
30.796875
54
0.511963
0.394958
1
0
0
yes
0.5
0.2
dnr before sadm
0
70
0.699951
112
42
39.79688
523.75
2.799805
1.699951
0.799927
138
7.539062
null
null
null
null
6
<2 mo. follow-up
6
44
1
25.40999
female
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
0
$11-$25k
0
8,032
5,697.8945
5,440.49609
13.5
white
22.199219
32
0.917969
0.887939
1
0
0
no
0.8
0.7
dnr after sadm
2
69
17.097656
106
26
39.39844
271.375
2.299805
1
1.399902
134
7.30957
null
null
null
null
2
no(M2 and SIP pres)
2
1,602
0
65.06494
male
0
18
COPD
COPD/CHF/Cirrhosis
3
8
null
0
23,400
17,767.0781
16,269.7969
26.666656
white
21
22
0.853882
0.758911
1
0
0
no
0.75
0.65
no dnr
18
102
13
122
10
36.5
188
2.799805
0.799927
0.799927
138
7.389648
null
null
null
null
6
adl>=4 (>=5 if sur)
6
1,590
1
27.61699
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
37
34,378
27,041.7188
25,375.9062
24.666656
white
32.398438
57
0.670898
0.574951
3
0
0
no
0.8
0.8
no dnr
21
128
12.5
122
54
38.09375
192.5
2.399902
4.899414
0.399963
140
7.419922
null
null
null
null
0
no(M2 and SIP pres)
0
1,600
0
86.45294
female
1
3
MOSF w/Malig
ARF/MOSF
2
null
under $11k
41
6,261
4,557.543
4,660.61719
3
white
29.199219
45
0.248993
0.144989
6
0
0
yes
0
0
dnr before sadm
-4
75
14.699219
80
12
35.09375
null
null
null
4.099609
133
null
null
null
null
null
6
<2 mo. follow-up
6
3
1
64.59094
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
63,159
46,434.3125
46,484.5
22.5
white
22
15
0.80188
0.735962
5
0
0
no
0.95
0.8
no dnr
26
108
20.199219
59
24
36.69531
278.5625
null
null
0.899902
128
7.419922
null
null
null
0
0
SIP>=30
0
1,598
0
65.547
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
17,531
13,567.3438
12,765.2734
20.5
white
20.097656
23
0.834961
0.778931
3
0
0
no
0.9
0.8
no dnr
7
123
10.798828
53
16
36.89844
205.6875
3.199707
0.5
1.5
140
7.439453
null
null
null
0
0
no(M2 and SIP pres)
0
1,598
0
72.474
male
0
3
CHF
COPD/CHF/Cirrhosis
4
4
under $11k
0
1,703
1,318.2285
1,267.12988
8
black
24.5
44
0.775879
0.642944
1
1
0
no
null
null
no dnr
3
93
6.399414
84
32
35.5
274.25
3.599609
1.5
3.299805
136
7.429688
null
null
null
1
null
no(M2 and SIP pres)
1.1669
591
1
88.28699
male
1
13
MOSF w/Malig
ARF/MOSF
1
13
null
44
36,616
25,085.9375
24,742.125
48
white
27
59
0.260986
0.154999
2
0
0
metastatic
0.95
0.5
dnr after sadm
9
111
20.199219
142
28
37.89844
169.09375
2.199707
1.899902
0.799927
145
7.479492
null
null
null
null
2
<2 mo. follow-up
2
13
1
79.23297
male
1
68
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
26
198,616
157,963.75
147,955.875
46.5
white
35.5
57
0.219971
0.122986
37
0
0
no
0.2
0.1
no dnr
68
62
66.796875
129
9
35.5
187.5
1.599854
0.599976
2.899902
129
7.359375
null
null
null
null
7
adl>=4 (>=5 if sur)
7
68
1
59.56998
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
under $11k
0
20,819
16,970.4844
15,891.3438
23
black
23.199219
30
0.821899
0.761963
2
0
0
no
0.4
0.3
dnr after sadm
2
126
10
114
14
35.29688
350.375
2.099609
0.399963
1.399902
146
7.379883
null
null
null
null
7
adl>=4 (>=5 if sur)
7
1,591
0
79.13995
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
0
8,804
5,774.4102
6,082.10938
27
white
22.296875
32
0.782959
0.711914
1
1
0
no
0.5
0.3
no dnr
7
106
11.099609
111
28
36
224.46875
3.099609
0.599976
1.099854
140
7.389648
null
null
null
3
4
no(M2 and SIP pres)
4
136
1
57.05698
female
0
3
Lung Cancer
Cancer
2
10
under $11k
0
1,661
1,254.2422
1,148.61914
8
white
15.199219
15
0.758911
0.503906
1
0
0
metastatic
0.5
0.2
no dnr
3
60
7.099609
80
20
36.59375
null
3.599609
0.299988
0.399963
138
null
null
null
null
0
0
no(M2 and SIP pres)
0
112
1
62.47198
male
0
4
Lung Cancer
Cancer
1
8
under $11k
0
2,276
1,799.4326
1,761.0498
16
hispanic
23.796875
10
0.556885
0.233978
1
0
0
metastatic
0.25
0.1
dnr after sadm
1
83
9.099609
110
24
36.29688
null
3.199707
0.399963
0.599976
135
null
null
null
null
2
null
<2 mo. follow-up
1.839
28
1
51.68198
male
0
10
MOSF w/Malig
ARF/MOSF
1
14
$25-$50k
0
12,063
7,601.918
8,637.76562
30
white
33.796875
50
0.448975
0.328979
2
0
0
yes
0.1
0.001
no dnr
10
93
0
136
24
39.79688
null
2
0.599976
1.599854
130
null
null
null
null
null
null
no(M2 and SIP pres)
3.039551
662
1
77.65594
male
1
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
54,414
42,434.5625
39,935
44
other
49
81
0.067993
0.023998
3
0
0
no
0.5
0.5
no dnr
16
64
4.099609
129
36
38.39844
107.09375
2.199707
3
3.799805
120
7.419922
null
null
null
null
null
<2 mo. follow-up
2.820313
16
1
41.45099
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
64,709
50,988.2812
47,956.125
27
white
23.597656
19
0.848999
0.795898
6
0
0
no
0.7
0.7
no dnr
29
111
14.298828
100
32
38.79688
248.375
2.699707
0.599976
0.799927
127
7.369141
null
null
null
null
null
no(M2 and SIP pres)
3.627441
1,585
0
53.465
male
0
7
Colon Cancer
Cancer
2
9
under $11k
0
5,161
3,808.4844
3,973.07812
9
black
25.5
23
0.702881
0.416992
1
0
0
metastatic
0.5
0.2
no dnr
7
121
10.298828
126
22
36.59375
null
3.299805
1.099854
1.199951
130
null
null
null
null
0
0
<2 mo. follow-up
0
37
1
83.39996
female
1
4
Coma
Coma
1
null
under $11k
100
3,172
2,325.7422
2,199.33984
6
white
27.398438
31
0.011999
0.004
1
0
0
yes
0
0
dnr after sadm
2
97
11.298828
104
42
36.39844
162.3125
3.899902
1.099854
1.599854
143
7.25
null
null
null
null
1
<2 mo. follow-up
1
4
1
56.83499
male
1
30
Cirrhosis
COPD/CHF/Cirrhosis
2
null
null
0
94,095
62,270.2188
63,474.9375
55
white
31.898438
77
0.570923
0.375977
1
0
0
no
0.1
0.001
dnr after sadm
29
64
7.5
144
40
34.89844
203
1.399902
4.899414
0.799927
135
7.439453
null
null
null
null
1
<2 mo. follow-up
1
30
1
48.65399
male
1
20
Lung Cancer
Cancer
2
14
under $11k
0
18,367
13,296.7344
12,566.8672
16
white
30
31
0.426941
0.121994
1
0
0
metastatic
0.2
0.05
dnr after sadm
8
80
8.5
110
26
35.69531
352.375
2.199707
0.399963
0.599976
130
7.459961
null
null
null
5
5
<2 mo. follow-up
5
20
1
58.50198
female
1
4
Coma
Coma
1
null
under $11k
100
27,599
19,816.7969
19,271.7344
39
white
42
38
0
0
15
0
0
no
null
null
dnr after sadm
2
42
27.097656
105
8
36
87.14062
null
null
0.799927
136
7.5
null
null
null
null
null
<2 mo. follow-up
3.177246
4
1
52.25699
female
1
4
Coma
Coma
0
15
$11-$25k
89
12,858
8,761.1094
8,791.20312
61
white
25.597656
49
0.314941
0.243988
2
0
0
no
null
null
no dnr
4
105
26.398438
141
28
39.5
220
3.399902
0.799927
0.799927
133
7.469727
null
null
null
null
null
<2 mo. follow-up
2.648926
4
1
72.08197
female
0
5
COPD
COPD/CHF/Cirrhosis
4
9
under $11k
0
4,243
2,803.6289
2,696.51953
12
white
18.097656
20
0.816895
0.702881
1
0
0
yes
0.6
0.6
dnr after sadm
2
67
10.5
108
24
35.69531
302
4.399414
0.599976
0.599976
133
7.369141
null
null
null
3
5
SIP>=30
5
122
1
36.85098
male
0
10
Cirrhosis
COPD/CHF/Cirrhosis
2
9
under $11k
0
7,314
5,446.1992
5,572.87891
2.5
white
20.699219
22
0.883911
0.805908
1
0
0
no
0.8
0.5
no dnr
10
79
7.199219
80
16
37.09375
null
2.699707
4.599609
0.399963
134
null
null
null
null
1
1
no(M2 and SIP pres)
1
1,579
0
30.66899
male
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
null
9
67,223
53,348.6875
48,977.9062
33
black
33
53
0.726929
0.642944
5
0
0
no
0.9
0.9
no dnr
36
70
19
129
34
39.19531
98.59375
2.199707
1.5
1.699951
143
7.369141
null
null
null
null
0
SIP>=30
0
1,577
0
73.43195
female
0
8
Lung Cancer
Cancer
2
8
under $11k
26
7,356
5,247.4062
5,422.06641
15
white
23.597656
34
0.394958
0.099991
1
0
0
metastatic
0.1
0.001
dnr after sadm
2
108
13.898438
118
28
36.39844
314.25
3.399902
1.299805
1
143
7.429688
null
null
null
null
6
<2 mo. follow-up
6
18
1
62.215
male
0
71
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
118,709
92,193.25
84,127.1875
34.25
white
32.09375
33
0.67688
0.581909
1
0
0
no
0.25
0.15
no dnr
71
73
17
131
26
38.09375
87.14062
2.5
1.799805
0.799927
147
7.419922
null
null
null
null
0
SIP>=30
0
74
1